10.64
price up icon2.01%   0.21
after-market After Hours: 10.75 0.11 +1.03%
loading
Forte Biosciences Inc stock is traded at $10.64, with a volume of 7,306. It is up +2.01% in the last 24 hours and down -16.61% over the past month. Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
See More
Previous Close:
$10.43
Open:
$10.65
24h Volume:
7,306
Relative Volume:
0.08
Market Cap:
$70.05M
Revenue:
-
Net Income/Loss:
$-31.48M
P/E Ratio:
-10.23
EPS:
-1.04
Net Cash Flow:
$-28.71M
1W Performance:
+9.92%
1M Performance:
-16.61%
6M Performance:
-33.00%
1Y Performance:
-25.00%
1-Day Range:
Value
$10.50
$10.77
1-Week Range:
Value
$9.23
$10.77
52-Week Range:
Value
$4.11
$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Name
Name
Forte Biosciences Inc
Name
Phone
(310) 618-6994
Name
Address
3060 PEGASUS PARK DRIVE, DALLAS, CA
Name
Employee
14
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
FBRX's Discussions on Twitter

Compare FBRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
FBRX
Forte Biosciences Inc
10.64 127.39M 0 -31.48M -28.71M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-21-25 Initiated TD Cowen Buy
Apr-08-24 Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-21 Upgrade Chardan Capital Markets Sell → Buy
Sep-03-21 Downgrade B. Riley Securities Buy → Neutral
Sep-03-21 Downgrade Chardan Capital Markets Buy → Sell
Sep-03-21 Downgrade Ladenburg Thalmann Buy → Neutral
Sep-03-21 Downgrade Truist Buy → Hold
May-14-21 Initiated B. Riley Securities Buy
Mar-26-21 Initiated Citigroup Buy
Aug-28-20 Upgrade Chardan Capital Markets Neutral → Buy
Aug-25-20 Initiated Truist Buy
View All

Forte Biosciences Inc Stock (FBRX) Latest News

pulisher
06:07 AM

What analysts say about Forte Biosciences Inc. stockTriple returns potential - jammulinksnews.com

06:07 AM
pulisher
02:59 AM

What drives Forte Biosciences Inc. stock priceFree AI-Backed Trading Signals - Autocar Professional

02:59 AM
pulisher
06:51 AM

Is Forte Biosciences Inc. a good long term investmentLightning-fast growth - jammulinksnews.com

06:51 AM
pulisher
Jul 22, 2025

How the (FBRX) price action is used to our Advantage - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Forte Biosciences Inc. stock price move sharplyDaily Swing Candidates - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Forte Biosciences Inc. Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

WVVI Stock Analysis and ForecastFree Bull & Bear Market Updates - Jammu Links News

Jul 18, 2025
pulisher
Jul 15, 2025

Why Forte Biosciences Inc. stock attracts strong analyst attentionHigh Potential Stock Ideas - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Forte Biosciences Inc. stock performs during market volatilityTop Momentum Stock Pick - Newser

Jul 15, 2025
pulisher
Jul 10, 2025

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World

Jul 10, 2025
pulisher
Jul 07, 2025

Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates - insights.citeline.com

Jul 07, 2025
pulisher
Jul 05, 2025

Forte Biosciences (FBRX): A Strategic Buy in Biotech's High-Reward Arena - AInvest

Jul 05, 2025
pulisher
Jul 05, 2025

individual investors who own 54% along with institutions invested in Forte Biosciences, Inc. (NASDAQ:FBRX) saw increase in their holdings value last week - Yahoo Finance

Jul 05, 2025
pulisher
Jul 01, 2025

(FBRX) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 01, 2025
pulisher
Jun 30, 2025

Forte Biosciences, Inc.(NasdaqCM: FBRX) added to Russell 3000E Index - MarketScreener

Jun 30, 2025
pulisher
Jun 28, 2025

FBRX SEC FilingsForte Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 26, 2025

Stock Sell-Offs Trigger Market Turmoil For Firms - Finimize

Jun 26, 2025
pulisher
Jun 26, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World

Jun 26, 2025
pulisher
Jun 25, 2025

Firm Advises Forte Biosciences on $75 Million Public Offering - Wilson Sonsini

Jun 25, 2025
pulisher
Jun 25, 2025

Forte Biosciences (FBRX) Plans $75 Million Public Offering - GuruFocus

Jun 25, 2025
pulisher
Jun 25, 2025

Forte Biosciences Announces Public Offering of Shares - TipRanks

Jun 25, 2025
pulisher
Jun 24, 2025

Forte Biosciences Announces Proposed Public Offering - Bluefield Daily Telegraph

Jun 24, 2025
pulisher
Jun 23, 2025

Forte’s celiac disease drug shows positive results in Phase 1b trial - Investing.com Nigeria

Jun 23, 2025
pulisher
Jun 23, 2025

Forte Biosciences Announces Positive Phase 1b Trial Results - TipRanks

Jun 23, 2025
pulisher
Jun 20, 2025

Forte Biosciences (FBRX) Soars 16.75% on Positive Clinical Trial Results - AInvest

Jun 20, 2025
pulisher
Jun 12, 2025

Valkyrie Balance Sheet Opportunities ETF (NYSEARCA:VBB) Trading 0.4% Higher – Here’s Why - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

With Forte Biosciences Up 28%, Insider Buyers Count Their Returns - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com

Jun 10, 2025
pulisher
Jun 05, 2025

Forte Biosciences (FBRX) Receives Buy Rating as FB-102 Shows Blockbuster Potential | FBRX Stock News - GuruFocus

Jun 05, 2025
pulisher
May 30, 2025

Forte Biosciences reports annual meeting results By Investing.com - Investing.com Nigeria

May 30, 2025

Forte Biosciences Inc Stock (FBRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Cap:     |  Volume (24h):